A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Adenovirus Serotype 26 Based Respiratory Syncytial Virus Pre-fusion (Ad26.RSV.Pre-F) Vaccine in RSV-Seronegative Toddlers 12 to 24 Months of AgeHigh-Dose Methotrexate in Treating Young Patients With Solid TumorsAtypical Hemolytic-Uremic Syndrome (aHUS) RegistryFirst Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation StudyLong-term Follow-up of Patients Treated With Autologous T Cells Genetically ModifiedSafety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel SyndromeA Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100)Study to Assess the Efficacy and Safety of Emapalumab in Primary Haemophagocytic LymphohistiocytosisA Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination TherapyA Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute LymphoblPhase III Study of Edasalonexent in Boys With Duchenne Muscular DystrophyA Study to Evaluate the Safety, Tolerability and Immunogenicity of an Investigational RSV Vaccine Candidate (Ad26.RSV.preF) in Adults 18 to 50 Years of Age, and RSV-seropositive Toddlers 12 to 24 Months of AgeStudy of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive ImpairmentOnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients
P6153
Q42416498-E61B9C3B-5702-410C-978A-96367C677560Q42843010-6F0FEE3A-7B10-443C-B040-845A35608AE4Q47400350-DFA7A8FF-2197-4D23-9553-3134DE2535A1Q53198113-D0324977-7E41-4349-8255-3DABB3566D05Q59174836-F196B55C-FF15-4DED-BD24-9B2470143C7BQ59220764-CDBF1AC9-0CE4-4194-8959-D6DB4FD9C083Q59688267-4745F60A-B3D9-4A5D-BD80-354B4B6BF9F9Q60169519-10DC0D7B-E7C3-4DA0-B276-B43EC38F6361Q60725885-7C660558-0E83-4A4B-8C4A-C0F94FBD3277Q63783587-748DF29E-FDB4-4319-A161-0DC6443B284AQ86969555-32137642-0BE6-4AB2-934F-AE286B801673Q88324106-D5116BA3-EA50-4906-B3A7-60CA44C423B1Q89752824-0DEE5776-8C19-4994-8E42-D51DC9F67B8F
P108
Q61907215-D5D0180C-848A-4DED-9774-F16F96C50B6AQ61978920-19464103-D2FD-4204-BF8D-4FF8A7F25498Q63319884-AA66E586-A393-4B2A-B5FE-F441409420A5Q63322475-107FC879-B7AC-4031-91F8-88381D4C2B66Q63393275-D4E4EBD3-4200-43C2-9A00-9CD0B5D9CDD5Q63397321-142BA10E-2300-486F-84AA-0FF6B1D38D1CQ63400461-620CE1DD-8E75-42A9-BF9D-CA3A004513F9Q63571376-6CA73E40-D452-49BD-A646-CCAE9321B834Q63571860-C995AFA1-0C99-4463-8E1D-26F2FAFD39F7Q63572193-8960CD53-6ABD-4CE1-B129-C9BDF8BA3D11Q63573484-3879992D-7F41-4DB1-869C-7B1A2D7FE7F6Q63575008-EAEBDEA2-8125-4016-B37F-399B5A424523Q64123465-4FAE48EE-0A4E-4B1B-A22E-E83B7F543802Q64220169-55DE9B28-5114-4829-A458-A54F2AD05E31
P6153
description
children's hospital in Chorlton-on-Medlock, Manchester, England
@en
rumah sakit di Britania Raya
@id
ziekenhuis in het Verenigd Koninkrijk
@nl
בית חולים בממלכה המאוחדת
@he
name
Royal Manchester Children's Hospital
@en
Royal Manchester Children's Hospital
@en-ca
Royal Manchester Children's Hospital
@en-gb
type
label
Royal Manchester Children's Hospital
@en
Royal Manchester Children's Hospital
@en-ca
Royal Manchester Children's Hospital
@en-gb
prefLabel
Royal Manchester Children's Hospital
@en
Royal Manchester Children's Hospital
@en-ca
Royal Manchester Children's Hospital
@en-gb
P214
P244
P213
0000 0001 0235 2382
P214
P2427
grid.415910.8
P244
n2007062873
P3500
P370
emergency:Level 1 Pediatric Trauma Center
P571
2009-01-01T00:00:00Z
P625
Point (-2.318611 53.506667)
P6782
P7859
lccn-n2007062873